Shukra Pharmaceuticals Balance Sheet Annual

BSE: 524632 | NSE: - | ISIN: INE551C01028 | Sector: Biotechnology & Drugs

60.64 +1.74 (2.95%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	9.98	3.97	0.09	0.50
Cashand Short Term Investments	9.98	3.97	0.09	0.50
Accounts Receivable- Trade Net	24.51	30.19	7.40	9.75
Total Receivables Net	26.83	32.72	10.52	13.21
Total Inventory	2.31	3.16	3.95	1.68
Other Current Assets Total	17.10	13.22	1.11	0.66
Total Current Assets	56.23	53.07	15.67	16.06
Property/ Plant/ Equipment Total- Net	21.60	21.89	19.24	19.35
Total Assets	77.84	74.97	35.11	35.61
Accounts Payable	7.22	34.25	8.59	5.33
Current Portof LT Debt/ Capital Leases	0.50	1.31	0.25	0.00
Other Currentliabilities Total	6.43	6.94	3.54	1.71
Total Current Liabilities	14.15	42.51	12.38	7.03
Long Term Debt	2.66	3.77	3.13	9.77
Total Long Term Debt	2.66	3.77	3.13	9.77
Total Debt	3.15	5.08	3.38	9.77
Deferred Income Tax	3.27	3.29	3.26	3.20
Other Liabilities Total	0.11	0.11	-	-
Total Liabilities	20.20	49.67	18.76	20.01
Common Stock Total	10.95	3.91	1.57	1.57
Other Equity Total	46.69	21.38	14.78	14.03
Total Equity	57.64	25.30	16.35	15.60
Total Liabilities Shareholders' Equity	77.84	74.97	35.11	35.61
Total Common Shares Outstanding	4.38	0.63	3.01	3.01
Tangible Book Valueper Share Common Eq	13.16	40.39	5.43	5.18
Notes Payable/ Short Term Debt	-	0.00	0.00	0.00
Long Term Investments	-	-	0.20	0.19